CNN Exclusive: Older weight loss drugs are making a comeback as Zepbound, Wegovy remain out of reach for many CNN Wegovy Claim Eligibility for Injured Consumers Atraxia Law The $800B Regulatory Divide: Why the FDA EMA Gap Is Now a Commercial Strategy Problem DrugPatentWatch Transform Data into Market Domination Michigan: What to Do After Losing Medicaid Coverage GoodRx Weight Loss Orlando Svelte Medical Weight Loss Centers Tens of millions of people around the world are now taking drugs like Ozempic a kind of real time experiment that offers far more data than a carefully controlled clinical trial can.